Condition: Epilepsy · Seizure · Sponsor: Sahlgrenska University Hospital
A growing body of evidence suggests patients with late-onset seizures are at an increased risk of stroke, but the potential for reducing cardiovascular morbidity through risk factor screening and management is unknown. The investigators aim to determine whether individuals with new-onset unprovoked seizures after middle age should undergo vascular risk assessment. In a cluster project the investigators assess the effect of vascular risk factor screening in an observational study as well as a cohort study. The project has two interlinked components: a prospective single group study, in which risk factor assessment is performed and subsequent management is followed for one year; and a register-based cohort study examining the long-term effects of the intervention on a system level.
This description comes directly from the study's public registry record.
Johan Zelano, MD PhD · +46313421000 · johan.zelano@neuro.gu.se
David Larson, MD PhD · +46313421000 · david.gw.larsson@vgregion.se
Always discuss trial participation with your own doctor first.
| Södra Älvsborg Sjukhus | Borås, Sweden | Recruiting |
| Salgrenska University Hospital | Gothenburg, Sweden | Recruiting |
| Skånes universitetssjukhus | Malmö, Sweden | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07116330